R. Inzelberg et al., APOLIPOPROTEIN E4 IN PARKINSON-DISEASE AND DEMENTIA - NEW DATA AND METAANALYSIS OF PUBLISHED STUDIES, Alzheimer disease and associated disorders, 12(1), 1998, pp. 45-48
The authors examined whether the epsilon 4 allele might be associated
with dementia in Parkinson disease (PD), given that the dementia of PD
shares neuroanatomic and neurochemical features with Alzheimer diseas
e (AD) and that many recent studies have found a high prevalence of th
e epsilon 4 allele of apolipoprotein E (ApoE) in AD. The authors exami
ned patients with PD (n = 125, 47 demented) and unrelated controls (n
= 93) using a short mental test. DNA was obtained from blood leukocyte
s. The relevant portion of the apolipoprotein E (ApoE) gene was amplif
ied by polymerase chain reaction, and the epsilon 4 allele was identif
ied using B restriction enzyme. The frequency of the ApoE epsilon 4 al
lele in demented patients with PD (14%) was not greater than that in n
ondemented patients (17%), whereas patients with PD as a whole showed
a trend toward a higher epsilon 4 allele frequency (16%) than age-matc
hed controls (10%, p = 0.07). The epsilon 4 allele frequency in nondem
ented patients with PD was significantly higher than in controls (p =
0.055). These results and the meta-analysis of four published reports
fail to support the hypothesis that the epsilon 4 allele is associated
with dementia in PD.